Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06330168
Other study ID # 36264PR573/2/24
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 28, 2024
Est. completion date April 10, 2025

Study information

Verified date February 2024
Source Tanta University
Contact Osama M Rehab, MD
Phone 01095210806
Email osamarehab@med.tanta.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This prospective randomized double-blinded controlled study will be conducted to evaluate the effect of adding calcitonin to bupivacaine in thoracic paravertebral block for patients undergoing thoracotomy.


Description:

Single-shot thoracic paravertebral block combined with intravenous analgesia is one of the regional techniques used for controlling pain in patients undergoing thoracic surgery. However, few articles demonstrated its effects on acute pain and chronic pain after thoracotomy and revealed high postoperative opioid consumption and inability to reduce the incidence of chronic pain. Calcitonin has previously been shown to be effective in the management of acute pain following amputation, vertebral fractures and other neuropathic conditions. Using calcitonin as an additive in thoracic paravertebral block was not evaluated in previous studies, we conducted this study as we hypothesize that calcitonin use as an additive in thoracic paravertebral block for patients undergoing thoracotomy may have extended analgesic effects regarding decreasing postoperative pain scores, opioid consumption, and this value may decrease the incidence of chronic post-thoracotomy pain. In both groups, ultrasound-guided thoracic paravertebral block will be performed before anesthetic induction using a high-frequency linear probe after identifying the paravertebral space of the proposed level of intercostal skin incision.General anesthesia in both groups will be similar.


Recruitment information / eligibility

Status Recruiting
Enrollment 48
Est. completion date April 10, 2025
Est. primary completion date April 10, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - aged = 18 years - American society of anesthesiology (ASA) physical status of I-III - scheduled for elective thoracotomy Exclusion Criteria: - Contraindication to thoracic paravertebral block as coagulopathy or local anesthetic allergy. - Pregnancy - History of cardiovascular and gastro-esophageal surgery - Preexisting pain syndrome or psychological disorders - Severe hepatic, cardiovascular, or renal disorders - Allergy to calcitonin - Patients who will be re-operated and who will report infections

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
bupivacaine-calcitonin-fentanyl
pre-induction single shot thoracic paravertebral block using 20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml), and 100 IU of calcitonin (1ml).
Bupivacaine-fentanyl
pre-induction single shot thoracic paravertebral block using 20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml), and 1 ml saline 0.9%.

Locations

Country Name City State
Egypt Tanta University Hospitals Tanta Gharbiya

Sponsors (1)

Lead Sponsor Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary morphine consumption total morphine consumption in the first 24 hours after surgery from the end of surgery until the end of the first postoperative day
Secondary numerical rating scale scores A 0-10 cm numerical rating scale ( 0 means no pain and 10 means the worst pain) at coughing and at rest will be assessed by an investigator during the first and second day post operation from arrival to the post-anesthesia care unit until 48 hour after surgery.
Secondary incidence of chronic pain chronic pain at 3 and 6 months after surgery 3 months and 6 months after surgery
Secondary Side effects hypotension, postoperative nausea and vomiting first postoperative day
See also
  Status Clinical Trial Phase
Completed NCT04579276 - Different Approaches to Thoracic Paravertebral Block N/A
Recruiting NCT05145153 - Incidence of Chronic Pain After Thoracic Surgery
Recruiting NCT05044858 - Ultrasound-Guided Mid-Point Transverse Process to Pleura Block for Thoracotomy Incisions N/A
Completed NCT00976313 - Does Thoracic Epidural Analgesia Influence Urinary Micturition by Patients Undergoing Thoracic Surgery? N/A
Terminated NCT00373633 - Extrapleural Intercostal Catheter vs. Thoracic Epidural for Thoracotomy Pain Phase 1
Completed NCT00498251 - Prevention of Lung Edema After Thoracic Surgery N/A
Terminated NCT05307471 - Physiopathologic Study of Induced by Thoracotomy / Thoracoscopy Neuropathy Mechanism
Completed NCT01698203 - Continuous Wound Catheter Analgesia Associated With Intravenous Morphine PCA After Thoracotomy Phase 4
Completed NCT04242160 - Comparison of Two Resuscitative Thoracotomy Techniques N/A
Terminated NCT00726258 - Association of Intravenous Ketamine With Thoracic Epidural Analgesia: Effects on Pain and Respiratory Function Following Thoracotomy. N/A
Withdrawn NCT00344097 - The Effects of Soy Protein on Post-thoracotomy Pain Phase 2
Completed NCT05083832 - Effect of Two Different Plane Blocks on Post-thoracotomy Pain N/A
Completed NCT02073760 - Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2
Completed NCT00910949 - Sensory Perception After Thoracotomy N/A
Completed NCT05496478 - Assesment of Complications and Surgery Timing in Postcovid Thoracotomy Patients: Single Center Experience
Completed NCT00746213 - Chronic Pain After Thoracotomy, an Incidence Study N/A
Recruiting NCT04252378 - Ultrasound-guided Deep and Superficial Serratus Anterior Plane Block N/A
Completed NCT03281213 - Acute Postthoracotomy Pain - Impact of Gender N/A
Recruiting NCT04220697 - Central Sensitisation and Postoperative Pain N/A
Completed NCT00224588 - KETOR: Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain Phase 3